These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7104552)

  • 21. Prediction of lithium response in affective disorders.
    Ananth J; Pecknold JC
    J Clin Psychiatry; 1978 Feb; 39(2):95-100. PubMed ID: 344305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lithium for maintenance treatment of mood disorders.
    Burgess S; Geddes J; Hawton K; Townsend E; Jamison K; Goodwin G
    Cochrane Database Syst Rev; 2001; (3):CD003013. PubMed ID: 11687035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind comparison of lithium carbonate and maprotiline in the prophylaxis of the affective disorders.
    Coppen A; Montgomery SA; Gupta RK; Bailey JE
    Br J Psychiatry; 1976 May; 128():479-85. PubMed ID: 776313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lithium treatment of a patient with Addison's disease and affective psychosis.
    Schulze Mönking H
    Pharmacopsychiatry; 1989 Mar; 22(2):84-6. PubMed ID: 2717662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effectiveness of lithium in the prophylaxis of affective disorders].
    Ezquiaga E; García-López A; Nieves P; Rodríguez-Salvanés F
    Actas Esp Psiquiatr; 2000; 28(3):156-60. PubMed ID: 11000697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Saliva for monitoring of patients with primary affective disorders.
    Ben-Aryeh H; Laor R; Szargel R; Gutman D; Naon H; Pascal M; Hefetz A
    Isr J Med Sci; 1984 Mar; 20(3):197-201. PubMed ID: 6427134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loudness dependence of primary auditory-cortex-evoked activity as predictor of therapeutic outcome to prophylactic lithium treatment in affective disorders--a retrospective study.
    Juckel G; Mavrogiorgou P; Bredemeier S; Gallinat J; Frodl T; Schulz C; Möller HJ; Hegerl U
    Pharmacopsychiatry; 2004 Mar; 37(2):46-51. PubMed ID: 15048610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy of affective disorders.
    Alexander B; Cook B
    Prim Care; 1990 Sep; 17(3):565-88. PubMed ID: 2236337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic lithium treatment of patients with affective disorders is associated with decreased platelet [3H]dihydroergocryptine binding.
    Wood K; Coppen A
    J Affect Disord; 1983 Aug; 5(3):253-8. PubMed ID: 6309936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of age on lithium therapy.
    Slater V; Milanes F; Talcott V; Okafor KC
    South Med J; 1984 Feb; 77(2):153-4, 158. PubMed ID: 6701582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CSF magnesium in affective disorder: lack of correlation with clinical course of treatment.
    George MS; Rosenstein D; Rubinow DR; Kling MA; Post RM
    Psychiatry Res; 1994 Feb; 51(2):139-46. PubMed ID: 8022948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lithium-induced EEG changes in patients with affective disorders.
    Schulz C; Mavrogiorgou P; Schröter A; Hegerl U; Juckel G
    Neuropsychobiology; 2000; 42 Suppl 1():33-7. PubMed ID: 11093069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma and red cell lithium in affective disorders.
    Alvarez Martinez E; Udina Ubello C; Queralto Compano JM; Casas Brugue M
    Br J Psychiatry; 1983 Sep; 143():311-2. PubMed ID: 6626848
    [No Abstract]   [Full Text] [Related]  

  • 34. Lithium RBC/plasma ratio in subgroups of patients with affective disorders.
    von Knorring L; Oreland L; Perris C; Runeberg S
    Neuropsychobiology; 1976; 2(2-3):74-80. PubMed ID: 1012450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced plasma cyclic AMP level during prophylactic lithium treatment in patients with affective disorders.
    Arató M; Rihmer Z; Felszeghy K
    Biol Psychiatry; 1980 Apr; 15(2):319-22. PubMed ID: 6251928
    [No Abstract]   [Full Text] [Related]  

  • 36. Lithium therapy.
    Dodds G
    Scott Med J; 2000 Dec; 45(6):171-3. PubMed ID: 11216307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug plasma levels and platelet 5-HT uptake inhibition during long-term treatment with fluvoxamine or lithium in patients with affective disorders.
    Wood K; Swade C; Abou-Saleh M; Milln P; Coppen A
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):365S-368S. PubMed ID: 6407498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early onset of lithium prophylaxis as a predictor of good long-term outcome.
    Franchini L; Zanardi R; Smeraldi E; Gasperini M
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(5):227-30. PubMed ID: 10591987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Instant lithium monitoring: a clinical revolution in the making.
    Srinivasan DP; Birch NJ
    Br J Clin Pract; 1996; 50(7):386-8. PubMed ID: 9015912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Puerperal affective disorders and response to lithium.
    Abou-Saleh MT; Coppen A
    Br J Psychiatry; 1983 May; 142():539. PubMed ID: 6871572
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.